Abiopharma

New Form 3 - PLUS THERAPEUTICS, INC. Filed: 2025-08-15 AccNo: 0000950170-25-109401 Size: 3 KB

New Form S-3/A - SYNLOGIC, INC. Filed: 2025-08-15 AccNo: 0001193125-25-181891 Size: 718 KB

New Form 424B4 - ABVC BIOPHARMA, INC. Filed: 2025-08-15 AccNo: 0001213900-25-077473 Size: 990 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001681622-25-000086 Size: 4 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001562180-25-005822 Size: 5 KB

New Form POS AM - NeuroSense Therapeutics Ltd. Filed: 2025-08-15 AccNo: 0001213900-25-077468 Size: 485 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001562180-25-005823 Size: 5 KB

New Form POS AM - NeuroSense Therapeutics Ltd. Filed: 2025-08-15 AccNo: 0001213900-25-077471 Size: 556 KB

New Form S-1/A - Odyssey Health, Inc. Filed: 2025-08-15 AccNo: 0001683168-25-006245 Size: 335 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001562180-25-005821 Size: 5 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001562180-25-005819 Size: 5 KB

New Form 10-Q - Monogram Technologies Inc. Filed: 2025-08-15 AccNo: 0001410578-25-001836 Size: 3 MB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001562180-25-005820 Size: 5 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001562180-25-005818 Size: 5 KB

New Form 8-K - Annovis Bio, Inc. Filed: 2025-08-15 AccNo: 0001104659-25-079248 Size: 192 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits